3Jeppesen MD, Hein H, Suadicani P, et al. Triglyeeride concentration and ischemic heart disease, an eight-year follow-up in the Copenhagen male study. Circulation, 1998,97 (11): 1029-1036.
4Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes,1992,41:715-722.
5Shaten J, Haffneer S, Stairs GD, et al. Low levels of sex hormone binding globulin and testosterone predict the incidence of non-insulin dependent diabetes mellitus in men: The multiple risk factor intervention trial. Diabetes, 1994,43 suppl : 60A.
6Lindstedt G, Lundberg PA, Lapidus L, et al. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM (12-Yr follow-up of population study of women in gothenburg, sweden). Diabetes, 1991,40:123-128.
7Diamond MP, Grainger D, Diamond MC, et al. Effects of methyhestos terone on insulin secretion and sensitivity in women. J Clin Endocrinol Metab, 1998,83:4420-4425.
8Pasquali R, Macor C, Vicennali V, et al. Effects of acute hyperinsulinmia on testosterone serum concentration in adult obese an normal-weight men. Metabolism, 1997,46 : 526-529.
9Ehrmann DA, Schnoider DJ, Sobel BE, et al. Troglitazone improve defect in insulin action, insulin secretion, pvarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997,82:2108-2116.
10Hauner H.Insulin resistance and the metabolic syndrome-a challenge of the new millennium[J],2002(Suppl 1).
